Ascletis Pharma, Inc. (HK:1672)
HKEX:1672
Hong Kong Market
Holding HK:1672?
Track your performance easily

Ascletis Pharma, Inc. (1672) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

1672 Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Ascletis
Pharma, Inc.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1672 Stock 12 Month Forecast

There Are No Analyst Ratings for HK:1672 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

1672 Financial Forecast

1672 Earnings Forecast

Next quarter’s earnings estimate for 1672 is -HK$0.16 with a range of -HK$0.16 to -HK$0.16. The previous quarter’s EPS was -HK$0.14. 1672 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.74% of the time in the same period. In the last calendar year 1672 has Underperformed its overall industry.
Next quarter’s earnings estimate for 1672 is -HK$0.16 with a range of -HK$0.16 to -HK$0.16. The previous quarter’s EPS was -HK$0.14. 1672 beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 39.74% of the time in the same period. In the last calendar year 1672 has Underperformed its overall industry.

1672 Sales Forecast

Next quarter’s sales forecast for 1672 is HK$0.00 with a range of HK$0.00 to HK$0.00. The previous quarter’s sales results were HK$0.00. 1672 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 43.36% of the time in the same period. In the last calendar year 1672 has Underperformed its overall industry.
Next quarter’s sales forecast for 1672 is HK$0.00 with a range of HK$0.00 to HK$0.00. The previous quarter’s sales results were HK$0.00. 1672 beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 43.36% of the time in the same period. In the last calendar year 1672 has Underperformed its overall industry.

Detailed List of Analyst Forecasts​

Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies
HK$3.8
Buy
261.90%
Upside
Reiterated
04/17/24
We expect (initial) determination from ITC to be announced on April 26 th 2024, which is important as favorable outcome would restore/open up out-licensing opportunities. Note net cash is HK$2.3/sh.
Goldman Sachs
HK$1.84HK$2.24
Hold
113.33%
Upside
Upgraded
01/30/24
Ascletis Pharma Inc (1672:HK) (ASCLF) PT Raised to HK$2.24 at Goldman SachsGoldman Sachs analyst Ziyi Chen raised the price target on Ascletis Pharma Inc (1672:HK) (OTC: ASCLF) to HK$2.24 (from HK$1.84) while maintaining a Neutral rating.

Best Analysts Covering Ascletis Pharma, Inc.

Which Analyst Should I Follow If I Want to Buy HK:1672 and Sell After:
1 Month
xxx
Success Rate
2/4 ratings generated profit
50%
Average Return
-3.98%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -3.98% per trade.
3 Months
xxx
Success Rate
0/4 ratings generated profit
0%
Average Return
-20.52%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -20.52% per trade.
1 Year
Chris LuiJefferies
Success Rate
0/4 ratings generated profit
0%
Average Return
-38.07%
reiterated a buy rating 5 months ago
Copying Chris Lui's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -38.07% per trade.
2 Years
xxx
Success Rate
0/4 ratings generated profit
0%
Average Return
-34.75%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -34.75% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1672 Analyst Recommendation Trends

Rating
Aug 23
Jan 24
Mar 24
Apr 24
Strong Buy
1
2
3
3
Buy
0
0
0
0
Hold
0
1
1
1
Sell
0
0
0
0
Strong Sell
0
0
0
0
total
1
3
4
4
In the current month, 1672 has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 1672 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

1672 Stock Forecast FAQ

What is HK:1672’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:1672’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:1672, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Ascletis Pharma, Inc. a Buy, Sell or Hold?
      Currently, no data Available
      What is Ascletis Pharma, Inc.’s share price target?
      Currently, no data Available
      What do analysts say about Ascletis Pharma, Inc.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Ascletis Pharma, Inc.?
      To buy shares of HK:1672, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis